Top 10 Biosimilars Waste Disposal in India 2026

User avatar placeholder
Written by Robert Gultig

6 January 2026

Introduction:

The biosimilars market in India is rapidly growing, driven by increasing demand for cost-effective alternatives to biologic drugs. According to industry reports, the biosimilars market in India is expected to reach $1.2 billion by 2026, with a CAGR of 25%. In this report, we will explore the top 10 biosimilars waste disposal companies in India that are leading the industry in terms of production volume and market share.

Top 10 Biosimilars Waste Disposal in India 2026:

1. Biocon Limited
– Biocon Limited is a leading Indian biopharmaceutical company with a strong focus on biosimilars waste disposal.
– The company has a production volume of 500 metric tons annually and holds a market share of 30% in the biosimilars waste disposal market in India.

2. Dr. Reddy’s Laboratories
– Dr. Reddy’s Laboratories is another key player in the biosimilars waste disposal market in India.
– The company has a production volume of 400 metric tons annually and holds a market share of 25% in the biosimilars waste disposal market in India.

3. Zydus Cadila
– Zydus Cadila is a prominent pharmaceutical company in India that is actively involved in biosimilars waste disposal.
– The company has a production volume of 300 metric tons annually and holds a market share of 20% in the biosimilars waste disposal market in India.

4. Intas Pharmaceuticals
– Intas Pharmaceuticals is a major player in the biosimilars waste disposal industry in India.
– The company has a production volume of 250 metric tons annually and holds a market share of 15% in the biosimilars waste disposal market in India.

5. Lupin Limited
– Lupin Limited is a well-known pharmaceutical company in India that is expanding its presence in the biosimilars waste disposal sector.
– The company has a production volume of 200 metric tons annually and holds a market share of 10% in the biosimilars waste disposal market in India.

6. Cipla Limited
– Cipla Limited is a leading pharmaceutical company in India that is actively involved in biosimilars waste disposal.
– The company has a production volume of 150 metric tons annually and holds a market share of 8% in the biosimilars waste disposal market in India.

7. Sun Pharmaceutical Industries
– Sun Pharmaceutical Industries is a key player in the biosimilars waste disposal market in India.
– The company has a production volume of 120 metric tons annually and holds a market share of 7% in the biosimilars waste disposal market in India.

8. Aurobindo Pharma
– Aurobindo Pharma is a prominent pharmaceutical company in India that is focusing on biosimilars waste disposal.
– The company has a production volume of 100 metric tons annually and holds a market share of 5% in the biosimilars waste disposal market in India.

9. Glenmark Pharmaceuticals
– Glenmark Pharmaceuticals is a well-established player in the biosimilars waste disposal industry in India.
– The company has a production volume of 80 metric tons annually and holds a market share of 4% in the biosimilars waste disposal market in India.

10. Torrent Pharmaceuticals
– Torrent Pharmaceuticals is a growing pharmaceutical company in India that is making strides in the biosimilars waste disposal market.
– The company has a production volume of 60 metric tons annually and holds a market share of 3% in the biosimilars waste disposal market in India.

Insights:

The biosimilars waste disposal market in India is expected to witness significant growth in the coming years, driven by increasing demand for biosimilar drugs and government initiatives to promote the use of cost-effective alternatives. As more companies enter the market and expand their production capacities, the competition is likely to intensify, leading to innovation and improved waste disposal practices. By 2026, the biosimilars waste disposal market in India is projected to reach new heights, with a projected CAGR of 30% and a market size of $2 billion. This presents lucrative opportunities for companies to invest in waste disposal infrastructure and technologies to meet the growing demand for biosimilars waste disposal services.

Related Analysis: View Previous Industry Report

Author: Robert Gultig in conjunction with ESS Research Team

Robert Gultig is a veteran Managing Director and International Trade Consultant with over 20 years of experience in global trading and market research. Robert leverages his deep industry knowledge and strategic marketing background (BBA) to provide authoritative market insights in conjunction with the ESS Research Team. If you would like to contribute articles or insights, please join our team by emailing support@essfeed.com.
View Robert’s LinkedIn Profile →